ea0081ep873 | Reproductive and Developmental Endocrinology | ECE2022
Glintborg Dorte
, Rubin Katrine Hass
, Kristensen Simon Bang
, Lidegaard Ojvind
, T'Sjoen Guy
, Hilden Malene
, Andersen Marianne Skovsager
Background: Gender affirming hormonal treatment (GAHT) is for many a cornerstone of transgender care. National data regarding use of hormonal treatment by transgender persons are limited.Aim: To assess use of GAHT in transgender persons.Design: National register-based cohort study in Danish transgender persons followed from 2000 until 2018. The main outcome measure was redemption of GAHT. Persons with an ICD-10 diagnosis code of &#...